article

CEIV Pharma: Industry cooperation that is taking off

Posted: 4 May 2016 | | No comments yet

Several air transport industry stakeholders and regulators have joined forces to create the Center of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV Pharma) programme. This joint effort aims to effectively help reverse the current lack of standardisation, compliance and transparency currently afflicting the pharmaceutical air transport supply chain, via mutual cooperation, honest sharing of data and a strong emphasis on accountability.

CEIV Pharma: Industry cooperation that is taking off

In order to fill this industry gap, several air transport industry stakeholders and regulators have joined forces to create the Center of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV Pharma) programme. This joint effort aims to effectively help reverse the current lack of standardisation, compliance and transparency currently afflicting the pharmaceutical air transport supply chain, via mutual cooperation, honest sharing of data and a strong emphasis on accountability.

An industry need for standardisation

The media cites that the pharmaceutical cold chain logistics industry will surpass the US$10 billion mark in 2018. Traditionally, this industry has relied heavily on air transport due to its speed and efficiency. However, over the past decade air cargo’s share of the overall global pharmaceutical product transport has been continuously declining. The use of air transportation has been reconsidered due to the level of annual product losses in air transport (up to US$12.5 billion) and the concurrent trend towards improved reliability in ocean freight.

In an effort to reduce overall levels of pharmaceutical mishandling, a growing number of countries are issuing their own cold chain regulations and guidance based around the non-air-cargo-specific good distribution practices (GDP). Although the focus on higher standards is a welcome initiative, the result has been the creation of a heavily regulated (and very difficult to manage) industry without global standards or universal certification for the handling and transportation of pharmaceutical products…

The rest of this article is restricted - login or subscribe free to access

european pharmaceutical review magazine cover issue 2 2018Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • bi-monthly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here

 

Send this to a friend